Shepherd Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
AmplifiDxamplifidx.comJul 2021
AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients.
BiotechDigital HealthFemTechHealthtechMedical DevicesPleasanton, US
Nancy Schoenbrunner(Chief Executive Officer)Shoulian Dong(Chief Scientific Officer)Daniel Schoener(Chief Product Officer)Chris Meda(Chief Commercial Officer)Ming Tan(Director)Sammy Datwani(Director)
Co-investorsBeacon AngelsSocial Starts
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.